Concepedia

Wakana Saso

WS

13

Publications

863

Citations

11

H-Index

2018

Active since

Affiliations

National Institute of Infectious Diseases(Current)

The University of Tokyo

Tokyo University of Science

Kyoto University

Institut National de la Transfusion Sanguine

Wakana Saso is an author at National Institute of Infectious Diseases specializing in medicine, virology, and immunology.

Top concepts

Publications per year

2018–2022

13

Publications

13

Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization

Masashi Iwamoto, Wakana Saso, Ryuichi Sugiyama et al. · Proceedings of the National Academy of Sciences · 2019 · 232 citations · Full text

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · iScience · 2021 · 180 citations · Full text

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · 2020 · 83 citations

, , +17

The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network

Masashi Iwamoto, Wakana Saso, Kazane Nishioka et al. · Journal of Biological Chemistry · 2020 · 61 citations · Full text

, , +21

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry

Toby Passioura, Koichi Watashi, Kento Fukano et al. · Cell chemical biology · 2018 · 60 citations

, , +9

Rows per page

1–5 of 13